
Doximity, Inc.: financial statements
Price
$33.34
November 13, 2026Market cap $6.1B
What Ploutos Investor adds for Doximity
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from FY2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Financial statements
Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.
Click a line to see it on the chart.
Revenue
| Line | FY2024 | FY2025 | FY2026 | Average a year |
|---|---|---|---|---|
| Revenue | $475M | $570M | $645M | |
| Cost of revenue | $51M | $56M | $70M | |
| Gross profit | $425M | $515M | $575M | |
| Operating income | $164M | $228M | $215M | |
| Net income | $148M | $223M | $196M | |
| Earnings per share | $0.72 | $1.11 | $0.98 | |
| Earnings per share, basic | $0.78 | $1.19 | $1.05 | |
| Margins | ||||
| Gross margin | 89.3% | 90.2% | 89.1% | |
| Operating margin | 34.5% | 39.9% | 33.3% | |
| Net margin | 31.0% | 39.1% | 30.4% | |
Financial statements
DOCS's revenue, profits and cash flows from FY2020 to FY2023, 4 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
By segment
Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.
- Subscription
- Service Other
- FY2024: Subscription $450M, Service Other $25M
- FY2025: Subscription $544M, Service Other $27M
- FY2026: Subscription $608M, Service Other $36M
| Product | FY2024 | FY2025 | FY2026 | Share FY2026 |
|---|---|---|---|---|
| Subscription | $450M | $544M | $608M | 94% |
| Service Other | $25M | $27M | $36M | 5.7% |
By segment
DOCS's revenue by product line from FY2021 to FY2023, 3 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
From the XBRL of 5 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.
Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.
Debt and obligations
What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.
Leases
Mar 31, 2026Operating leases
$10M
Finance leases
–
The liability is the present value of the rent still to pay, at March 31, 2026. It is not counted in the ladder's debt. The filing
Goodwill by segment
Mar 31, 2026Total goodwill
$85M
The company does not state its goodwill by segment, at March 31, 2026. The filing
From the statutory to the effective tax rate, FY2026
Mar 31, 2026Statutory rate
21.0%
Effective rate
21.6%
The company paid 21.6% in tax on its profit, 0.6 points above the US federal rate (21.0%). Below, the reasons it gives.
Statutory rate
21.0%
Share-based compensation
-5.0 pts
Difference the filing does not itemize
+5.6 pts
Effective rate
21.6%
One point is 1% of profit before tax. The lines are as the company states them in the notes to its annual report. The filing
Earnings quality
How the reported earnings were made, read from the filings. A description, not a score: our tests found no link between these measures and later share returns.
Where the change in earnings per share came from
Diluted earnings per share went from $1.11 in the fiscal year to Mar 31, 2025 to $0.98 in the year to Mar 31, 2026, a change of -$0.12.
Measured by size, 25.6% of the movement came from outside sales and operating margin: interest and other items, the tax rate, what went to others and the share count.
- +$0.11
- -$0.16
- $0.00
- -$0.08
- +$0.01
Earnings per share is split as sales times operating margin, plus interest and other items, after tax, times the part that goes to the common shareholders, divided by the diluted share count. Each source's part is its average effect over every order in which the six can change, so the parts add up exactly to the change. From the annual reports; net income over the diluted count matches the earnings per share the company filed within 2%.
Receivables and inventory against sales
In the quarter to Sep 30, 2026, sales were +3.6% on the same quarter a year earlier, and receivables +28.5%.
- Days of sales in receivables rose more than at nine in ten S&P 500 companies.
- a year earlier 70 days
- 87 days
Balances at Sep 30, 2026 and Sep 30, 2025, against the sales and cost of sales of the quarter ending on each date; a fourth quarter is the fiscal year less its first nine months. Same quarter against same quarter, so the season is the same.
Allowance for doubtful accounts
The allowance for receivables that may not be collected was 1.0% of gross receivables at Sep 30, 2026, against 1.2% a year earlier.
At last year's share it would be $268.1K larger. A smaller allowance means a smaller charge for bad debts in profit.
- a year earlier $1.5M
- $1.7M
Taxes: deferred and paid
The deferred part was 59.6% of the tax charge in the year to Mar 31, 2026. The rows show the last 3 years.
Cash taxes paid were 100.0% of the current tax charge in the year to Mar 31, 2026.
- Deferred share, year to Mar 31, 2026$32M of $54M
- 59.6%
- Deferred share, year to Mar 31, 2025-$12M of $40M
- -28.7%
- Deferred share, year to Mar 31, 2024-$8.6M of $38M
- -22.8%
- $22M paid, $22M current
- 100.0%
When profit in the accounts runs ahead of taxable profit, the deferred part grows. It also moves for reasons unrelated to how earnings are booked: tax-law changes, the use of past losses, and the US rule since 2022 that spreads research costs over five years. Where the notes report it, the tax-rate bridge under Debt and obligations shows how the rate gets from the statutory one to the effective one.
A reading is called out when it is above the 90th percentile of the same reading across the S&P 500, or, for a fall, below the 10th, as measured on 9 November 2026. Each part uses only the company's own filings.
The full analysis
What do Doximity's filings show?
These are Doximity's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
How much revenue did DOCS have in FY2026?
Doximity had revenue of $645M and net income of $196M in fiscal FY2026, a net margin of 30.4%.
How much debt does DOCS have?
On March 31, 2026 Doximity had total assets of $1.1B, debt of – and shareholders' equity of $951M.
How much free cash flow does DOCS have?
In fiscal FY2026 Doximity had cash from operations of $326M and spent – on capital expenditure, leaving $326M of free cash flow.
Where are the figures from?
From Doximity, Inc.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.